Liam Ratcliffe, Director at ARRAY BIOPHARMA INC (ARRY), sold 577,286 shares at $5.87 ($3.3M) on 2013-09-04, disclosed to the SEC on 2013-09-06.
Open-market sale of $3.3M ARRY by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.87 | 236,116 | $1.4M | 41.5% |
| 2 | $5.77 | 201,598 | $1.2M | 34.8% |
| 3 | $5.68 | 139,572 | $793K | 23.7% |
| Total | $5.79 avg | 577,286 | $3.3M | 100% |
| Filing → |
| ARVN | SELL | 2021-11-09 | $30.9M | — | Filing → |
| ARVN | BUY | 2020-12-21 | $10.0M | — | Filing → |
| PASG | BUY | 2020-03-13 | $9.9M | — | Filing → |